Monthly Archives: July 2019

New PectaSol-C® Modified Citrus Pectin Study Shows Critical Support for Cardiac Function

New PectaSol-C® Modified Citrus Pectin Study Shows Critical Support for Cardiac Function

The blockage of blood flow to organs by a cardiac event of any type, can have significant impacts when circulation is reintroduced. Termed “reperfusion,” the return of blood flow may seem like a good thing; however, it can result in severe consequences for organ and tissue function. A new independent study demonstrates that PectaSol-C® Modified Citrus Pectin (MCP) provides critical support in this area, by inhibiting the actions of rogue protein Galectin-3.
Study Reveals Key to Beating Lyme

Study Reveals Key to Beating Lyme

It’s estimated that Lyme infects 20,000 to 30,000 people each year, mostly in the northeast United States, as well as Northern California, Minnesota and Wisconsin. If detected early, the infection can be treated with a heavy round of antibiotics. However, delayed diagnosis and treatment can lead to a chronic, highly debilitating condition that can persist for years.